نتایج جستجو برای: tp53 mutation and expression

تعداد نتایج: 16973495  

Background: Diagnostic molecular marker studies are in vogue to have insight of most prevalent animal diseases including cancer.Objectives: Gene expression profi ling of pro and anti-apoptotic genes was conducted in dog Lymphoma, CTVT, SCC, granuloma, perianal adenocarcinoma and mammary tumors.Materials and Methods: Cancerous tissue...

Journal: :Molecular cancer therapeutics 2015
Chunxiao Xu Kevin A Buczkowski Yanxi Zhang Hajime Asahina Ellen M Beauchamp Hideki Terai Yvonne Y Li Matthew Meyerson Kwok-Kin Wong Peter S Hammerman

Genetically engineered mouse models of lung cancer have demonstrated an important role in understanding the function of novel lung cancer oncogenes and tumor-suppressor genes identified in genomic studies of human lung cancer. Furthermore, these models are important platforms for preclinical therapeutic studies. Here, we generated a mouse model of lung adenocarcinoma driven by mutation of the d...

Journal: :Cancer research 2003
Yoshifumi Okada Edward E Hurwitz John M Esposito Melissa A Brower Catherine L Nutt David N Louis

Epidermal growth factor receptor (EGFR) gene amplification occurs in glioblastomas as so-called double minutes. Because double minutes are extrachromosomal fragments, selection pressures must operate to maintain high EGFR copy number over multiple cell divisions. In analyses of glioblastoma lysates, EGFR amplification has been observed almost exclusively in glioblastomas harboring wild-type TP5...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Marlon Lindenbergh-van der Plas Ruud H Brakenhoff Dirk J Kuik Marijke Buijze Elisabeth Bloemena Peter J F Snijders C René Leemans Boudewijn J M Braakhuis

PURPOSE TP53 is a key gene in cellular homeostasis and is frequently mutated in head and neck squamous cell carcinoma (HNSCC). There is a variety of TP53 mutations, each with its own biological and clinical implication. Aim of the study was to assess the prognostic significance of TP53 mutations in HNSCCs and to identify the most relevant mutation. EXPERIMENTAL DESIGN TP53 mutation status was...

Journal: :Cancer research 2001
S B Lee S H Kim D W Bell D C Wahrer T A Schiripo M M Jorczak D C Sgroi J E Garber F P Li K E Nichols J M Varley A K Godwin K M Shannon E Harlow D A Haber

Li Fraumeni Syndrome (LFS) is a multicancer phenotype, most commonly associated with germ-line mutations in TP53. In a kindred with LFS without an inherited TP53 mutation, we have previously reported a truncating mutation (1100delC) in CHK2, encoding a kinase that phosphorylates p53 on Ser(20). Here, we describe a CHK2 missense mutation (R145W) in another LFS family. This mutation destabilizes ...

2014
Heather R. Shive Robert R. West Lisa J. Embree Champa D. Golden Dennis D. Hickstein

Germline mutations in the tumor suppressor genes BRCA2 and TP53 significantly influence human cancer risk, and cancers from humans who inherit one mutant allele for BRCA2 or TP53 often display loss of the wildtype allele. In addition, BRCA2-associated cancers often exhibit mutations in TP53. To determine the relationship between germline heterozygous mutation (haploinsufficiency) and somatic lo...

2015
Chunxiao Xu Kevin A. Buczkowski Yanxi Zhang Hajime Asahina Ellen M. Beauchamp Hideki Terai Yvonne Y. Li Matthew Meyerson Peter S. Hammerman

Genetically engineered mouse models of lung cancer have demonstrated an important role in understanding the function of novel lung cancer oncogenes and tumor-suppressor genes identified in genomic studies of human lung cancer. Furthermore, these models are important platforms for preclinical therapeutic studies. Here, we generated a mouse model of lung adenocarcinoma driven by mutation of the d...

2013
Ashraf Mohamadkhani Elnaz Naderi Maryam Sharafkhah Hamid Reza Fazli Malihe Moradzadeh Akram Pourshams

The TP53 gene encodes tumor protein p53 which play a major role in the etiology of pancreatic cancer. The important role of codon 249 of TP53 for binding of p53 to its sequence-specific consensus site in DNA has been revealed by crystallography's studies, and mutation at this codon was detected in the plasma of some human cancers. The TP53 Mut assessor software within the International Agency f...

2014
Nathalia M Cury Victor EF Ferraz Wilson A Silva

BACKGROUND Approximately 5-10% of breast cancers are hereditary. Among hereditary syndromes, Hereditary Breast and Ovarian Cancer Syndrome (HBOC) and Li-Fraumeni Syndrome (LFS) have received the most attention. HBOC is due to mutations in the BRCA1 and BRCA2 genes and is characterized by breast adenocarcinoma and/or epithelial ovarian carcinoma. LFS is associated with germline mutations in TP53...

2015
Lili Sun Anh Tuan Nguyen Jan M. Spitsbergen Zhiyuan Gong

Hepatocellular carcinoma (HCC) is currently one of the top lethal cancers with an increasing trend. Deregulation of MYC in HCC is frequently detected and always correlated with poor prognosis. As the zebrafish genome contains two differentially expressed zebrafish myc orthologs, myca and mycb, it remains unclear about the oncogenicity of the two zebrafish myc genes. In the present study, we dev...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید